PRESS RELEASE published on 10/12/2023 at 21:05, 1 year 1 month ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
PRESS RELEASE published on 10/04/2023 at 10:02, 1 year 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 09/01/2023 at 15:38, 1 year 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 08/01/2023 at 14:08, 1 year 3 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 07/21/2023 at 07:05, 1 year 4 months ago Sartorius Stedim Biotech SA: Information on Document Availability
PRESS RELEASE published on 07/21/2023 at 07:00, 1 year 4 months ago Sartorius Stedim Biotech SA: Half-year results 2023 of Sartorius Stedim Biotech
PRESS RELEASE published on 07/18/2023 at 13:15, 1 year 4 months ago Sartorius Stedim Biotech SA: Sartorius Stedim Biotech completes acquisition of Polyplus
PRESS RELEASE published on 07/05/2023 at 13:55, 1 year 4 months ago Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
PRESS RELEASE published on 07/04/2023 at 08:54, 1 year 4 months ago DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
PRESS RELEASE published on 06/16/2023 at 22:30, 1 year 5 months ago Sartorius Stedim Biotech lowers forecast for 2023
Published on 11/22/2024 at 13:30, 12 minutes ago Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024
Published on 11/22/2024 at 13:30, 12 minutes ago American Battery Materials Receives Approvals to Reenter Exploration Well in Utah
Published on 11/22/2024 at 13:20, 22 minutes ago Guanajuato Silver Reports 2nd Consecutive Quarter of Positive Mine Operating Income
Published on 11/22/2024 at 13:15, 27 minutes ago AmeriTrust Announces Third Quarter 2024 Financial Results
Published on 11/22/2024 at 13:00, 42 minutes ago Redishred Capital Corp. to be Acquired by VRC Companies, LLC
Published on 11/22/2024 at 11:54, 1 hour 48 minutes ago PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 1 hour 57 minutes ago How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 2 hours 21 minutes ago Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 2 hours 36 minutes ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 06:58, 1 day 6 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 18 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 19 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 19 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
